Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol Plus Hydrocortisone Ointment for Facial and Intertriginous Psoriasis
NCT00704262Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- May 2008
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of calcipotriol, hydrocortisone in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started May 2008; status: completed.
02
Drugs
calcipotriolhydrocortisone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00704262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00704262.